Researchers utilize a number of models of Parkinson"s disease ranging in complexity from immortalized cell lines to nonhuman primates. These models are used to investigate everything from the mechanisms underlying neurodegeneration, to drugs that may improve patient outcomes. Each model system has advantages and disadvantages, depending on their application. In this review, the authors assess the potential value of embryonic stem and induced-pluripotent stem cells as additions to the crowded Parkinson"s disease in vitro model landscape.
- Parkinson"s disease
- embryonic stem cells
- induced pluripotent stem cells